のど用トローチ市場：製品タイプ別、適応症別、タイプ別、流通チャネル別、地域別

のど用トローチの世界市場は、2024年に45億9,000万米ドルと推定され、2024年から2031年にかけてCAGR5.8％を示し、2031年には68億米ドルに達すると予測されます。

図.のど用トローチ市場シェア（%）、2024年地域別

のど用トローチは、のどの炎症や痛みを和らげることを目的とした薬用キャンディーまたは錠剤です。風邪、咳、その他の喉の感染症が各地域で流行していることなどが、のど用トローチの需要を押し上げています。健康意識の高まりと、迅速な緩和を目的とした市販薬への嗜好が、市場の成長を促進すると予想されます。のど用トローチは、消費者の好みに合わせてさまざまなフレーバーが用意されているため、人気が高まっています。しかし、一部の新興国では代替治療の選択肢や認知度の低さが市場成長の妨げになる可能性があります。

市場力学：

のど用トローチの世界市場成長の原動力は、ライフスタイルや気候条件の変化によるのど感染症の罹患率の増加です。都市部における汚染レベルの上昇により、都市生活者のどの炎症リスクが高まっており、多忙なスケジュールやストレスレベルの上昇により免疫力が低下しています。このため、医療介入なしに喉の不調を素早く緩和したいというニーズが高まり、のど用トローチの売上が伸びています。しかし、のど用トローチの過剰摂取による副作用や、のどスプレーやうがい薬などの代替治療が利用可能であることなどが、市場の成長を妨げています。企業は、健康志向の消費者に対応するため、オーガニックやハーブ配合の製品を発売する機会を探っています。これらのトローチの新しいフレーバーに注力することで、市場成長の新たな機会を提供することができます。

本調査の主な特徴

• 本レポートでは、のど用トローチの世界市場を詳細に分析し、2023年を基準年とした予測期間（2024年～2031年）の市場規模（10億米ドル）と複合年間成長率（CAGR%）を掲載しています。
• また、さまざまなセグメントにわたる潜在的な収益成長機会を明らかにし、この市場の魅力的な投資提案マトリックスについて解説しています。
• また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
• 企業ハイライト、製品ポートフォリオ、主要なハイライト、業績、戦略などのパラメータに基づいて、のど用トローチの世界市場における主要企業をプロファイルしています。
• 主要企業には、Novartis AG、Cipla、Procter &Gamble、GSK plc、Sanofi、Lozen Pharma、Bliss GVS Pharma Ltd.、Honibe、Ricola、Prestige Consumer Healthcare Inc.、Traditional Medicinals, Inc.、MondelA "z International、Inova Pharmaceuticals、Johnson &Johnson Services, Inc.、Reckitt Benckiser Group PLCなどが含まれます。
• 本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
• のど用トローチの世界市場は、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界のさまざまな利害関係者に対応しています。
• 利害関係者は、世界のど用トローチ市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー
• Coherent Opportunity Map（COM）

第3章 市場力学、規制、動向分析

• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• 影響分析
• 市場動向
• 主な発展
• 規制シナリオ
• 買収と提携のシナリオ
• 資金調達と投資
• PEST分析
• ポーターの分析

第4章 世界ののど用トローチ市場- コロナウイルス（COVID-19）パンデミックの影響

• 全体的な影響
• 政府の取り組み
• COVID-19による市場への影響

第5章 世界ののど用トローチ市場、製品タイプ別、2019年-2031年

• ハードキャンディトローチ
• ソフトトローチ
• 圧縮トローチ

第6章 世界ののど用トローチ市場、適応症別、2019年-2031年

• 喉の痛み
• 咳と風邪
• 喉の病気

第7章 世界ののど用トローチ市場、タイプ別、2019年-2031年

• OTC
• 処方箋

第8章 世界ののど用トローチ市場、流通チャネル別、2019年-2031年

• 病院薬局
• 小売薬局
• オンライン薬局

第9章 世界の喉用ドロップ市場、地域別、2019年-2031年

第10章 競合情勢

• 企業プロファイル
  • Novartis AG
  • Cipla
  • Procter &Gamble
  • GSK plc
  • Sanofi
  • Lozen Pharma
  • Bliss GVS Pharma Ltd.
  • Honibe
  • Ricola
  • Prestige Consumer Healthcare Inc.
  • Traditional Medicinals, Inc
  • Mondelez International
  • Inova Pharmaceuticals
  • Johnson &Johnson Services, Inc.
  • Reckitt Benckiser Group PLC

第11章 アナリストの提言

• Wheel of Fortune
• アナリストの見解
• Coherent Opportunity Map

第12章 参考文献と調査手法

• 参考文献
• 調査手法

Global throat lozenges market is estimated to be valued at USD 4.59 Bn in 2024 and is expected to reach USD 6.80 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.8% from 2024 to 2031.

Figure. Throat Lozenges Market Share (%), By Region 2024

Throat lozenges are medicated candies or tablets that are intended to relieve throat irritation and soreness. Factors such as increasing prevalence of common cold, cough and other throat infections across regions boosts demand for throat lozenges. Rising health awareness and preference for over-the-counter medications for quick relief are expected to drive the market growth. The availability of throat lozenges in a wide range of flavors, catering to different consumer preferences, has boosted their popularity. However, alternative treatment options and lack of awareness in some emerging nations can hamper the market growth.

Market Dynamics:

Global throat lozenges market growth is driven by growing incidence of throat infections due to changing lifestyles and climatic conditions. Rising pollution levels in urban areas have increased the risk of throat irritation among city dwellers and busy schedules and higher stress levels have weakened immunity. This has boosted the need for fast relief from throat problems without medical intervention, thus, boosting sales of throat lozenges. However, factors such as side-effects of excessive lozenge intake and availability of alternative treatment in the form of throat sprays and gargles hampers the market growth. Companies are exploring opportunities to launch organic and herbal formulations to cater to health-conscious consumers. Focus on new flavors of these lozenges can offer new opportunities for the market growth.

Key Features of the Study:

• This report provides an in-depth analysis of the global throat lozenges market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global throat lozenges market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this includes Novartis AG, Cipla, Procter & Gamble, GSK plc, Sanofi, Lozen Pharma, Bliss GVS Pharma Ltd., Honibe, Ricola, Prestige Consumer Healthcare Inc., Traditional Medicinals, Inc, MondelA"z International, Inova Pharmaceuticals, Johnson & Johnson Services, Inc., Reckitt Benckiser Group PLC.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global throat lozenges market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global throat lozenges market.

Detailed Segmentation-

• By Product Type:
  • Hard candy lozenges
  • Soft lozenges
  • Compressed lozenges
• By Indication:
  • Sore throat
  • Cough and Cold
  • Throat diseases
• By Type:
  • OTC
  • Prescription
• By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Novartis AG
  • Cipla
  • Procter & Gamble
  • GSK plc
  • Sanofi
  • Lozen Pharma
  • Bliss GVS Pharma Ltd.
  • Honibe
  • Ricola
  • Prestige Consumer Healthcare Inc.
  • Traditional Medicinals, Inc
  • MondelA"z International
  • Inova Pharmaceuticals
  • Johnson & Johnson Services, Inc.
  • Reckitt Benckiser Group PLC

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By Indication
  • Market Snapshot, By Type
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Throat Lozenges Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Throat Lozenges Market, By Product Type, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• Hard candy lozenges
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Soft lozenges
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Compressed lozenges
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Throat Lozenges Market, By Indication, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• Sore throat
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Cough and Cold
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Throat diseases
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Throat Lozenges Market, By Type, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• OTC
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Prescription
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Throat Lozenges Market, By Distribution Channel, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• Hospital Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Online Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

9. Global Throat Lozenges Market, By Region, 2019 - 2031, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2019-2031
  • Regional Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.S.
    • Canada
    • Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

10. Competitive Landscape

• Company Profiles
  • Novartis AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cipla
  • Procter & Gamble
  • GSK plc
  • Sanofi
  • Lozen Pharma
  • Bliss GVS Pharma Ltd.
  • Honibe
  • Ricola
  • Prestige Consumer Healthcare Inc.
  • Traditional Medicinals, Inc
  • Mondelez International
  • Inova Pharmaceuticals
  • Johnson & Johnson Services, Inc.
  • Reckitt Benckiser Group PLC

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact